The safety profile of long-term, high-dose intraocular corticosteroid delivery
Authors:
- Nancy M. HolekampNHNancy M. Holekamp
- Matthew A. ThomasMTMatthew A. Thomas
- Andrew PearsonAPAndrew Pearson
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 139 (3) , 421-428
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndromeAmerican Journal of Ophthalmology, 2003
- Noninfectious Endophthalmitis Associated With Intravitreal Triamcinolone InjectionArchives of Ophthalmology (1950), 2003
- A Randomized Clinical Trial of a Single Dose of Intravitreal Triamcinolone Acetonide for Neovascular Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2003
- Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degenerationBritish Journal of Ophthalmology, 2002
- Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cellsGraefe's Archive for Clinical and Experimental Ophthalmology, 2001
- Thalidomide and Prednisolone Inhibit Growth Factor-Induced Human Retinal Pigment Epithelium Cell Proliferation in vitroOphthalmologica, 2001
- Intravitreal Triamcinolone Acetonide Inhibits Choroidal Neovascularization in a Laser-Treated Rat ModelArchives of Ophthalmology (1950), 2001
- INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2000
- Exudative macular degeneration and intravitreal triamcinolone: 18 month follow upAustralian and New Zealand Journal of Ophthalmology, 1998
- Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cellsEuropean Journal of Pharmacology, 1998